Literature DB >> 4075612

Treatment with cortisone plus heparin or hexuronyl hexoaminoglycan sulfates of murine tumors and their lung deposits.

L Milas, N Hunter, I Basic.   

Abstract

Heparin, cortisone, and combination of these two drugs were used for treatment of solitary tumors and artificial lung metastases of the fibrosarcoma NFSA and the mammary carcinoma MCA-K in C3Hf/Kam mice. Heparin reduced the number of artificial metastases of both tumors, but it did not affect the s.c. growth of these tumors. Conversely, cortisone reduced both the number of artificial metastases and the growth rate of s.c. tumors. The effect of cortisone was not further influenced by heparin. Cortisone showed a tendency for causing enhancement of spontaneous metastases. In addition, two heparin analogs, hexuronyl hexoaminoglycan sulfates were studied against MCA-K solitary tumors and their spontaneous metastases. They were ineffective when given alone, and they did not influence the effect of cortisone on the s.c. tumor growth. However, they slightly reduced the cortisone-induced enhancement of spontaneous metastases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4075612     DOI: 10.1007/BF01585080

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  11 in total

1.  Cortisone-induced metastases of adenocarcinoma in mice.

Authors:  M AGOSIN; R CHRISTEN; O BADINEZ; G GASIC; A NEGHME; O PIZARRO; A JARPA
Journal:  Proc Soc Exp Biol Med       Date:  1952-05

2.  Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.

Authors:  L Milas; N Hunter; K Mason; H R Withers
Journal:  Cancer Res       Date:  1974-01       Impact factor: 12.701

3.  Role of NK cells in the antimetastatic effect of anticoagulant drugs.

Authors:  E Gorelik; W W Bere; R B Herberman
Journal:  Int J Cancer       Date:  1984-01-15       Impact factor: 7.396

4.  Increase in radiosensitivity of lung micrometastases by hyperbaric oxygen.

Authors:  L Milas; N M Hunter; H Ito; W A Brock; L J Peters
Journal:  Clin Exp Metastasis       Date:  1985 Jan-Mar       Impact factor: 5.150

5.  Nonspecific Immunotherapy of Murine Solid Tumors With Corynebacterium granulosum.

Authors:  L Milas; B Hunter; K Mason; D Grdina; H Withers
Journal:  J Natl Cancer Inst       Date:  1975-04       Impact factor: 13.506

6.  Combination heparin plus cortisone treatment of two transplanted tumors in C3H/He mice.

Authors:  M Penhaligon; R S Camplejohn
Journal:  J Natl Cancer Inst       Date:  1985-04       Impact factor: 13.506

7.  Effect of hydrocortisone on the macrophage content, growth and metastasis of transplanted murine tumors.

Authors:  R Acero; N Polentarutti; B Bottazzi; S Alberti; M R Ricci; A Bizzi; A Mantovani
Journal:  Int J Cancer       Date:  1984-01-15       Impact factor: 7.396

8.  Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone.

Authors:  J Folkman; R Langer; R J Linhardt; C Haudenschild; S Taylor
Journal:  Science       Date:  1983-08-19       Impact factor: 47.728

9.  Endothelial cell proliferation as a novel approach to targeting tumour therapy.

Authors:  J Denekamp
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

10.  Isolation of a tumor factor responsible for angiogenesis.

Authors:  J Folkman; E Merler; C Abernathy; G Williams
Journal:  J Exp Med       Date:  1971-02-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Radiation enhancement of metastasis: a review.

Authors:  C F von Essen
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

2.  Effects of glycosaminoglycans and extracellular matrix components on metastatic rat rhabdomyosarcoma tumor and myoblast cell proliferation.

Authors:  F Redini; E Moczar; M F Poupon
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

3.  Cortisone inhibition of tumor angiogenesis measured by a quantitative colorimetric assay in mice.

Authors:  K E Lee; M Iwamura; A T Cockett
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 4.  Impact of venous thromboembolism and anticoagulation on cancer and cancer survival.

Authors:  Nicole M Kuderer; Thomas L Ortel; Charles W Francis
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

5.  Hepatic artery dexamethasone infusion inhibits colorectal hepatic metastases: a regional antiangiogenic therapy.

Authors:  Y Arisawa; E Sutanto-Ward; L Fortunato; E R Sigurdson
Journal:  Ann Surg Oncol       Date:  1995-03       Impact factor: 5.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.